Veracyte, Inc.

Veracyte, Inc.verified

VCYT

Price:

$20.8

Market Cap:

$1.59B

Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; Percepta Genomic Sequencing Classifier and Percepta Nasal Swab Test for lung cancer diagnosis; Envisia Genomic Classifier for diagnosing interstitial lung disease, including idiopathic pulmonary fibrosis; and Immunoscore Colon Cancer test for colon cancer diagnosis. It is also developing Percepta Genomic Atlas to hel...[Read more]

Industry

Biotechnology

IPO Date

2013-10-30

Stock Exchange

NASDAQ

Ticker

VCYT

The PE Ratio as of May 2024 (TTM) for Veracyte, Inc. (VCYT) is -22.37

According to Veracyte, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -22.37. This represents a change of -70.51% compared to the average of -75.85 of the last 4 quarters.

Veracyte, Inc. (VCYT) Historical PE Ratio (quarterly & annually)

How has VCYT PE Ratio performed in the past?

The mean historical PE Ratio of Veracyte, Inc. over the last ten years is -30.83. The current -22.37 PE Ratio has changed 7.16% with respect to the historical average. Over the past ten years (40 quarters), VCYT's PE Ratio was at its highest in in the June 2016 quarter at -3.12. The PE Ratio was at its lowest in in the September 2019 quarter at -399.36.

Quarterly (TTM)
Annual

Average

-30.83

Median

-23.55

Minimum

-78.16

Maximum

-5.54

Veracyte, Inc. (VCYT) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Veracyte, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 285.99%

Maximum Annual PE Ratio = -5.54

Minimum Annual Increase = -49.07%

Minimum Annual PE Ratio = -78.16

Quarterly (TTM)
Annual
YearPE RatioChange
2023-26.86-42.16%
2022-46.4425.46%
2021-37.02-49.07%
2020-72.68-7.01%
2019-78.16285.99%
2018-20.25183.38%
2017-7.150.41%
2016-7.1228.40%
2015-5.54-22.12%
2014-7.12201.89%

Veracyte, Inc. (VCYT) Average PE Ratio

How has VCYT PE Ratio performed in the past?

The current PE Ratio of Veracyte, Inc. (VCYT) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-36.77

5-year avg

-52.23

10-year avg

-30.83

Veracyte, Inc. (VCYT) PE Ratio vs. Peers

How is VCYT’s PE Ratio compared to its peers?

Veracyte, Inc.’s PE Ratio is less than Crinetics Pharmaceuticals, Inc. (-14.57), less than Viridian Therapeutics, Inc. (-3.39), less than Cytokinetics, Incorporated (-9.28), less than Structure Therapeutics Inc. (-17.64), less than Icosavax, Inc. (-8.27), less than Kura Oncology, Inc. (-10.57), less than Protagonist Therapeutics, Inc. (11.42), greater than Merus N.V. (-23.28), less than Replimune Group, Inc. (-1.49), less than Cerevel Therapeutics Holdings, Inc. (-16.30), less than Enanta Pharmaceuticals, Inc. (-1.93), less than Syndax Pharmaceuticals, Inc. (-7.18), less than Ventyx Biosciences, Inc. (-1.40), less than uniQure N.V. (-0.78), less than Rocket Pharmaceuticals, Inc. (-8.04), less than Rhythm Pharmaceuticals, Inc. (-8.07), less than Solid Biosciences Inc. (-3.29), less than MeiraGTx Holdings plc (-4.57), less than IDEAYA Biosciences, Inc. (-21.97), less than AnaptysBio, Inc. (-3.92), less than Keros Therapeutics, Inc. (-8.91), less than Homology Medicines, Inc. (-0.01),

Build a custom stock screener for Veracyte, Inc. (VCYT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Veracyte, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Veracyte, Inc. (VCYT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Veracyte, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Veracyte, Inc.'s PE Ratio?

How is the PE Ratio calculated for Veracyte, Inc. (VCYT)?

What is the highest PE Ratio for Veracyte, Inc. (VCYT)?

What is the 3-year average PE Ratio for Veracyte, Inc. (VCYT)?

What is the 5-year average PE Ratio for Veracyte, Inc. (VCYT)?

How does the current PE Ratio for Veracyte, Inc. (VCYT) compare to its historical average?